Deutsche Bank raised the firm’s price target on Novartis (NVS) to CHF 120 from CHF 115 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
- Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
- Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
- Trump Trade: Pharma tariff announcement likely ‘weeks away’
- Pharma tariff announcement likely ‘weeks away,’ Reuters reports